Podcast: Surviving the "valley of death" - How early-stage life sciences companies can overcome funding gaps and IP hurdles
Blog Post
08 March 2023
Author
Browse this blog post
Related news and insights
Blog Post: 29 September 2023
Intellectual Property Due Diligence Considerations in the Gaming Industry
News: 29 September 2023
Allen & Overy advises on financing for Cinven’s takeover offer for Synlab
Blog Post: 25 September 2023
The Online Safety Act (OSA) is finally here - businesses now turn to implementation questions
Blog Post: 22 September 2023
Tine Carmeliet, Juno Hautekiet and Geert Glas discuss how early-stage life sciences companies can survive the so-called “valley of death”. This is the funding gap between making a promising scientific discovery in a laboratory setting and the translation of the scientific findings into human applications and potential treatments for a disease, and is a widely recognized problem.
Our life sciences experts focus on the challenges growth companies face and why it is important to make the right legal decisions early on. They discuss, among other things:
- the importance of properly organising seed funding during pre-clinical trial stages;
- the maintenance of intellectual property rights and the potential impact of university-funded research; and
- the unpredictable and expensive nature of clinical trials, and how to manage these challenges to successfully navigate the “valley of death”.
You can listen to the podcasts on the following:
